Markets / Mutual funds / Equity ETFs
Aditya Birla Sun Life Mutual Fund · Index & ETFs fund · Regular plan · Growth
Index & ETFs fund in the Equity ETFs category, from Aditya Birla Sun Life Mutual Fund.
| Share of fund | 31 Oct 2026 | 30 Sept 2026 | Change |
|---|---|---|---|
| Stocks held | 100.0% | 100.0% | +0.01 |
| Short positions | -0.2% | -0.7% | +0.45 |
| Cash & others | 0.0% | 0.0% | -0.01 |
| Top 10 stocks | 76.4% | 75.9% | +0.48 |
| Number of stocks | 20 | 20 | 0 |
Change is in percentage points. Bought more and cut back list stocks whose share of the fund moved by at least 0.25 points. A share can also move because the price changed, not only because the fund traded.
| Holding | % of fund |
|---|---|
| Sun Pharmaceutical Industries Ltd. INE044A01036 | 16.32% |
| Divi's Laboratories Ltd. INE361B01024 | 10.78% |
| Laurus Labs Ltd. INE947Q01028 | 8.12% |
| Apollo Hospitals Enterprise Ltd. INE437A01024 | 7.54% |
| Dr. Reddy's Laboratories Ltd. INE089A01031 | 7.15% |
| Cipla Ltd. INE059A01026 | 6.73% |
| Torrent Pharmaceuticals Ltd. INE685A01028 | 5.89% |
| Max Healthcare Institute Ltd. INE027H01010 | 5.55% |
| Lupin Ltd. INE326A01037 | 4.23% |
| Aurobindo Pharma Ltd. INE406A01037 | 4.03% |
| Fortis Healthcare Ltd. INE061F01013 | 3.47% |
| Glenmark Pharmaceuticals Ltd. INE935A01035 | 3.00% |
| Alkem Laboratories Ltd. INE540L01014 | 2.68% |
| Zydus Lifesciences Ltd. INE010B01027 | 2.68% |
| Mankind Pharma Ltd. INE634S01028 | 2.45% |
| IPCA Laboratories Ltd. INE571A01038 | 2.32% |
| Gland Pharma Ltd. INE068V01023 | 2.14% |
| Biocon Ltd. INE376G01013 | 2.13% |
| Krishna Institute of Medical Sciences Ltd. INE967H01025 | 1.62% |
| Abbott India Ltd. INE358A01014 | 1.16% |
| Holding | % of fund |
|---|---|
| Net Receivable / Payable | -0.24% |
| Holding | % of fund |
|---|---|
| TREPS | 0.25% |
From the fund house's monthly portfolio (mutualfund.adityabirlacapital.com), as on 31 Oct 2026. Percentages are of the fund's net assets; short positions are negative. Published about ten days after each month ends.
Volatility: how much the NAV moves, as a yearly figure (higher = bumpier). Worst fall: the biggest drop from a high, in the NAV history we hold (from 6 Nov 2026).
| Fund size (average AUM, July - September 2026) | ₹81.44 cr across all plans |
| Fund house | Aditya Birla Sun Life Mutual Fund |
| Category | Index & ETFs · Equity ETFs |
| Plan | Regular |
| Option | Growth |
| Expense ratio (TER) | Direct 0.00% · Regular 0.22% (5 Nov 2026) |
| Minimum investment | For Subscription / Redemption of units directly with Mutual Fund: Subscription / Redemption facility directly with the Mutual Fund would be restricted to Authorized Participants and Large Investors. - Units of scheme may be subscribed to / redeemed only in Creation Unit size & in multiples thereof. - Authorised Participants and Large Investors may subscribe to/redeem the units of the scheme on any business day directly with the Mutual Fund at applicable NAV and transaction cost, if any, by depositing/receiving physical gold of defined purity (fineness) and quantity and /or cash, value of which is equivalent to Creation Unit size. For Purchase / Sale of units through Stock Exchange: All categories of Investors may purchase the units of the Scheme through the Stock exchange on which the units of the scheme are listed on any trading day in round lot of 1 (one) Unit at the prevailing listed price |
| Scheme code (AMFI) | 149262 |
| ISIN | INF209KB10C2 |
| NAV date | 6 Nov 2026 |
Scheme details from the fund's scheme summary document filed with AMFI; expense ratios from AMFI's daily filings.
Information only, not investment advice.
₹17.4203 as of 6 Nov 2026, from AMFI's official NAV data.
Returns appear once enough NAV history is available.
Both invest in the same portfolio. Direct plans are bought straight from the fund house and pay no distributor commission, so their expenses are lower and their NAV grows slightly faster.